Literature DB >> 26279695

Papillary Thyroid Carcinoma Metastasis to the Lumbar Spine Masquerading as a Schmorl's Node.

Cory P Daignault1, Edwin L Palmer2, James A Scott2, John S Swan2, Gilbert H Daniels3.   

Abstract

A Schmorl's node is a common incidental finding encountered during radiologic imaging. Despite the vertebral body being a common site of metastatic disease, a lytic lesion adjacent to an endplate with typical imaging features can often confidently be called a Schmorl's node. This is a case report of a patient with a single well-defined FDG-avid papillary thyroid carcinoma metastasis to the spine that had imaging findings characteristic of a Schmorl's node on CT and MRI. This case is important to consider as it demonstrates that the imaging characteristics of metastatic disease and Schmorl's nodes can overlap.

Entities:  

Keywords:  FDG; MRI; PET; Schmorl’s node; Thyroglobulin; Thyroid cancer

Year:  2015        PMID: 26279695      PMCID: PMC4532686          DOI: 10.1007/s13139-015-0320-x

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  21 in total

Review 1.  Schmorl's nodes.

Authors:  Kwaku A Kyere; Khoi D Than; Anthony C Wang; Shayan U Rahman; Juan M Valdivia-Valdivia; Frank La Marca; Paul Park
Journal:  Eur Spine J       Date:  2012-04-28       Impact factor: 3.134

2.  Schmorl's node mimicking metastasis in a patient with breast cancer: diagnosis with 99mTC methylene diphosphonate SPECT-CT.

Authors:  Harmandeep Singh; Punit Sharma; Niraj Naswa; Aftab Hasan Nazar; Bangkim Chandra Khangembam; Manas Kumar Sahoo; Rakesh Kumar
Journal:  Clin Nucl Med       Date:  2012-07       Impact factor: 7.794

3.  Evaluation of Schmorl's nodes using F-18 FDG PET/CT.

Authors:  C-Y Lin; H-Y Chen; H-J Ding; Y-K Chen; C-H Kao
Journal:  Clin Radiol       Date:  2012-05-17       Impact factor: 2.350

Review 4.  Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole-body scanning.

Authors:  Chao Ma; Anren Kuang; Jiawei Xie; Tiekun Ma
Journal:  J Nucl Med       Date:  2005-09       Impact factor: 10.057

5.  Schmorl's nodes distribution in the human spine and its possible etiology.

Authors:  Gali Dar; Youssef Masharawi; Smadar Peleg; Nili Steinberg; Hila May; Bahaa Medlej; Natan Peled; Israel Hershkovitz
Journal:  Eur Spine J       Date:  2009-12-12       Impact factor: 3.134

6.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

7.  Edematous Schmorl's nodes on thoracolumbar MR imaging: characteristic patterns and changes over time.

Authors:  Hung-Ta H Wu; William B Morrison; Mark E Schweitzer
Journal:  Skeletal Radiol       Date:  2006-02-10       Impact factor: 2.199

8.  Thyroglobulin levels and thyroglobulin doubling time independently predict a positive 18F-FDG PET/CT scan in patients with biochemical recurrence of differentiated thyroid carcinoma.

Authors:  Luca Giovanella; Pierpaolo Trimboli; Frederik A Verburg; Giorgio Treglia; Arnoldo Piccardo; Luca Foppiani; Luca Ceriani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-03-06       Impact factor: 9.236

9.  Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine.

Authors:  W Wang; S M Larson; R M Tuttle; H Kalaigian; K Kolbert; M Sonenberg; R J Robbins
Journal:  Thyroid       Date:  2001-12       Impact factor: 6.568

Review 10.  Radioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastases.

Authors:  Chao Ma; Anren Kuang; Jiawei Xie
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.